| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 01/31/2001 | CN1281862A Three-chain formed oligonucleotide capable of inhibiting platelet derived growth factor gene expression and its application |
| 01/31/2001 | CN1061350C 2.7-substituted octahydro-pyrrolo (1.2-A) pyrazine derivatives |
| 01/31/2001 | CN1061346C Diazabicycloalkene derivatives and use, and drug composition containing said derivatives |
| 01/31/2001 | CN1061341C 1-amino-ethylindole-derivatives |
| 01/31/2001 | CN1061260C Traditional Chinese medicine preparation for curing heart disease |
| 01/31/2001 | CN1061256C External-use blood pressure reducing ointment |
| 01/31/2001 | CN1061252C Chinese medicine oxygen nebulization preparation for curing cardio-cerebral disease and preparing method |
| 01/30/2001 | US6180791 Synthesis of 8-substituted xanthines |
| 01/30/2001 | US6180786 Antagonist for excitory amino acids |
| 01/30/2001 | US6180759 Process for the preparation of azacycloalkylakanoyl pseudotetrapeptides |
| 01/30/2001 | US6180676 Guanylhydrazones and their use to treat inflammatory conditions |
| 01/30/2001 | US6180665 Crystalline polymorphic form of (S,S,S)-N-(1-[2-carboxy-3 (N2-mesyllyslamino) propyl]-1- cyclopentylcarbonyl) tyrosine |
| 01/30/2001 | US6180664 Pentaerythritol derivatives, their production and use and intermediates for their synthesis |
| 01/30/2001 | US6180656 Use of condensated (hetaryl-substituted) 1-benzal-3-pyrazol derivates for treating special diseases of the cardiovascular and the central nervous systems |
| 01/30/2001 | US6180650 Antiinflammatory agents; respiratory system disorders; skin disorders; antitumor agents |
| 01/30/2001 | US6180645 Antiepilepic agent |
| 01/30/2001 | US6180643 Antagonist of interleukins, tumor necrosis factor |
| 01/30/2001 | US6180635 Novel thieno(2,3-d)pyrimidinediones which exhibit pharmacological activity, in particular immunosuppressive activity; treating allograft rejection |
| 01/30/2001 | US6180632 Use of these compounds for treating disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or t cell activation and proliferation |
| 01/30/2001 | US6180627 Antithrombotic agents |
| 01/30/2001 | US6180619 Prenyl transferase inhibitors |
| 01/30/2001 | US6180618 Propanolamine derivatives linked to bile acids, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/30/2001 | US6180615 Propargyl phenyl ether A2A receptor agonists |
| 01/30/2001 | US6180611 Inhibitors of matrix metalloproteinases and tumor necrosis factor |
| 01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
| 01/30/2001 | US6180384 Compounds |
| 01/30/2001 | US6180085 Useful for optical tomographic, endoscopic, photoacoustic and sonofluoresence applications for detection and treatment of tumors and other abnormalities |
| 01/30/2001 | CA2272317C Pharmaceutical composition comprising a compound having anti-xa activity and a platelet aggregation antagonist compound |
| 01/30/2001 | CA2238098C Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
| 01/29/2001 | CA2314682A1 A novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/28/2001 | CA2314572A1 Estrogen agonists and antagonists for multiple indications |
| 01/25/2001 | WO2001006262A1 Diagnostics and therapeutics for macular degeneration |
| 01/25/2001 | WO2001006261A2 Screening for therapeutic agents being scap antagonists |
| 01/25/2001 | WO2001006018A1 Antisense modulation of map kinase kinase 6 expression |
| 01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
| 01/25/2001 | WO2001005974A2 The il-1l1 gene and polypeptide products |
| 01/25/2001 | WO2001005972A1 Compositions and methods for the treatment of immune related diseases |
| 01/25/2001 | WO2001005969A2 Electron transfer proteins |
| 01/25/2001 | WO2001005947A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | WO2001005937A2 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | WO2001005834A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | WO2001005810A2 CYCLIC PEPTIDE DERIVATIVES AS INHIBITORS OF INTEGRIN αVβ¿6? |
| 01/25/2001 | WO2001005783A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | WO2001005776A1 Aminothiazole derivatives and their use as crf receptor ligands |
| 01/25/2001 | WO2001005771A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | WO2001005770A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | WO2001005765A1 Cyclic amides and imides having selective antagonist activity at alpha-1d adrenergic receptor |
| 01/25/2001 | WO2001005764A2 Sulfuric acid mono-[3-({1- [2-(4-fluoro-phenyl)-ethyl]- piperidin-4-yl}- hydroxy- methyl)-2- methoxy-phenyl]ester |
| 01/25/2001 | WO2001005762A2 Biphenyl derivatives, production thereof and use as mtp inhibitors |
| 01/25/2001 | WO2001005756A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors |
| 01/25/2001 | WO2001005753A1 Diacylhydrazine derivatives |
| 01/25/2001 | WO2001005751A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005749A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005746A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005745A1 AMINOBENZOPHENONES AS INHIBITORS OF IL-1β AND TNF-$g(a) |
| 01/25/2001 | WO2001005744A1 Novel aminobenzophenones |
| 01/25/2001 | WO2001005743A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | WO2001005428A1 Preventives for the recurrence of cerebrovascular failure and agents for ameliorating troubles following cerebrovascular failure and inhibiting progress thereof |
| 01/25/2001 | WO2001005418A2 Tissue regenerating agent |
| 01/25/2001 | WO2001005404A1 Use of beta-napthoquinone for making medicines having an inhibiting effect on the release of glutamate by the brain |
| 01/25/2001 | WO2001005399A1 Anti-ischemic agent |
| 01/25/2001 | WO2001005394A1 Agents inhibiting chronic rejection reactions after organ transplantation |
| 01/25/2001 | WO2001005390A2 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | WO2001005388A2 Use of a fatty derivative for the treatment of external secretiondisorders |
| 01/25/2001 | WO2001005353A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
| 01/25/2001 | WO2000071515A3 INHIBITORS OF FACTOR Xa |
| 01/25/2001 | WO2000067731A3 Medicinal substance utilization for preventing nitrate tolerance |
| 01/25/2001 | WO2000066587A3 Polyamines and their use in therapy |
| 01/25/2001 | WO2000064892A3 Thiazolidinedione derivative and its use as antidiabetic |
| 01/25/2001 | WO2000061171A3 Uses of mammalian ox2 protein and related reagents |
| 01/25/2001 | WO2000060080A3 Molecules of the immune system |
| 01/25/2001 | WO2000059940A3 Platelet-derived growth factor related gene and protein |
| 01/25/2001 | WO2000058473A3 Nucleic acids including open reading frames encoding polypeptides; 'orfx' |
| 01/25/2001 | WO2000054815A3 Expression of dna or proteins in c. elegans |
| 01/25/2001 | WO2000053211A3 Method of promoting myocyte proliferation and myocardial tissue repair |
| 01/25/2001 | WO2000044740A3 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors |
| 01/25/2001 | DE19933926A1 Biphenylderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenyl derivatives, their preparation and their use as medicaments |
| 01/25/2001 | DE19933421A1 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate 2-benzyl-3-dimethylamino-1-phenyl-propanderi- derivatives |
| 01/25/2001 | DE19933164A1 Neue Carbonsäurederivate mit 5,6 substituiertem Pyrimidinring, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten New carboxylic acid derivatives with 5,6-substituted pyrimidine ring, their preparation and use as endothelin receptor antagonists |
| 01/25/2001 | CA2381327A1 Human tumor necrosis factor receptors tr13 and tr14 |
| 01/25/2001 | CA2379554A1 Benzimidazolone derivatives and their use as phosphodiesterase inhibitors |
| 01/25/2001 | CA2379545A1 Novel carboxylic acid derivatives with 5,6 substituted pyrimidine ring, the production and utilization thereof as endothelin receptor antagonists |
| 01/25/2001 | CA2379319A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379316A1 Novel aminobenzophenones |
| 01/25/2001 | CA2379293A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379286A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379273A1 Aminobenzophenones as inhibitors of il-1.beta. and tnf-.alpha. |
| 01/25/2001 | CA2379064A1 Bradykinin b1 receptor antagonists |
| 01/25/2001 | CA2379041A1 Diacylhydrazine derivatives |
| 01/25/2001 | CA2379022A1 Cyclic peptide derivatives as inhibitors of integrin .alpha.v.beta.6 |
| 01/25/2001 | CA2378954A1 The il-1l1 gene and polypeptide products |
| 01/25/2001 | CA2378930A1 Electron transfer proteins |
| 01/25/2001 | CA2378917A1 Melanin-concentrating hormone receptor |
| 01/25/2001 | CA2378723A1 3-amino-2-benzyl-1-phenyl-propane derivatives |
| 01/25/2001 | CA2378249A1 Use of fviia or a tissue factor antagonist for regulating gene expression and cell migration or chemotaxis |
| 01/25/2001 | CA2378026A1 Novel glycosyl sulfotransferases gst-4.alpha., gst-4.beta., and gst-6 |
| 01/25/2001 | CA2377092A1 Method for treating chronic pain using mek inhibitors |
| 01/25/2001 | CA2376518A1 Conversion of a watson-crick dna to a hoogsteen-paired duplex |
| 01/25/2001 | CA2375458A1 Compositions and methods for the treatment of immune related diseases |
| 01/24/2001 | EP1070727A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |